303
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Regulatory bodies and health care systems should systematically evaluate the safety and cost-effectiveness of new cardiovascular treatments in health care registries using prospectively designed protocols

Article: 2343383 | Received 04 Jan 2024, Accepted 10 Apr 2024, Published online: 02 May 2024

Figures & data

Figure 1. The pathway from testing to implementing new treatments or medical devices. Few new cardiovascular drugs and devices are systematically evaluated for their safety and efficacy after implementation.

Figure 1. The pathway from testing to implementing new treatments or medical devices. Few new cardiovascular drugs and devices are systematically evaluated for their safety and efficacy after implementation.